NEW YORK, July 20, 2011 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) (Frankfurt:HL1) (“Alliqua” or the “Company”), an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and wound care technologies, today announced that it has acquired from Noble Biomaterials, Inc. (“Noble Biomaterials”) a 10 year exclusive global license for two wound care dressings, with an additional 10 year renewal option. These two products utilize X-STATIC®, Noble Biomaterial’s proprietary silver-based antimicrobial fiber used for advanced wound care, infection control and odor elimination.
